NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced the presentation of data yesterday highlighting…
New white-labeled solution "Opie AI" enhances pediatric workflows to reduce administrative burden and improve quality of care AUSTIN, Texas--(BUSINESS WIRE)--#HealthTech--Insight…
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#ArtificialIntelligence--The Hazelden Betty Ford Foundation, a leader in non-profit addiction and behavioral health treatment for 75 years,…
Schoox will deliver access to educational resources, programs, certification courses, and more. AUSTIN, Texas, April 9, 2025 /PRNewswire/ -- Schoox, a…
HONOLULU, April 09, 2025 (GLOBE NEWSWIRE) -- Arialief is a premium dietary supplement specifically designed to target the root causes…
CTx-2103 has the Potential to be the First, Once-Daily Formulation of Buspirone, one of the Most Widely Prescribed Agents in…
CT-95 is a mesothelin x CD3 T cell engaging bispecific antibody CT-95 is Context’s second T cell engaging bispecific antibody…
WARREN, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing…
– Clinical and preclinical data supporting dosing profile and tolerability for ABI-5366, a novel long-acting helicase-primase inhibitor candidate, featured in…
Exceptional provider ratings highlight ReMedi’s physician-led approach to improving clinical workflows and EHR efficiency. HOUSTON--(BUSINESS WIRE)--#EHR--ReMedi Health Solutions, a physician-led…